Acuity Brands
AYI
$304.84
-1.27%
Acuity Inc. (NYSE: AYI) is a leading industrial technology company operating in the Electrical Equipment & Parts industry, with two reportable segments: Acuity Brands Lighting (ABL), which sells commercial, architectural, and specialty lighting products and control systems, and Acuity Intelligent Spaces (AIS), which provides building management and audio/visual solutions for intelligent buildings. The company is a dominant player in the North American lighting market, leveraging a vast independent sales network and direct corporate relationships to serve commercial, industrial, and retail customers. The current investor narrative centers on Acuity's transformation from a traditional lighting manufacturer into a broader intelligent building solutions provider, with the AIS segment representing a key growth vector. Recent quarterly results have shown margin expansion and double-digit earnings growth, but the stock has faced pressure due to broader market rotation and concerns about commercial construction exposure. The recent news highlights a selective market environment where execution matters, and Acuity's ability to beat earnings expectations will be critical to sustaining its premium valuation.…
AYI
Acuity Brands
$304.84
Investment Opinion: Should I buy AYI Today?
Based on the synthesis of analyst consensus, valuation, and growth prospects, Acuity earns a 'Hold' rating with a bullish bias. The average analyst target price of $384.43 implies a 24.5% upside, and the consensus recommendation is 'Buy' (mean 2.25), reflecting confidence in the company's margin expansion and cash flow generation. However, the recent downgrade and weak revenue growth warrant caution, suggesting that the stock is fairly valued at current levels with potential for upside if execution improves.
The supporting evidence for a Hold is compelling: the forward PE of 13.23x is attractive, especially with a PEG ratio of 0.53, indicating undervaluation relative to growth. Revenue growth is modest at 1.65% year-over-year, but profitability is strong with a net margin of 11.77% and operating margin of 16.14%, both improved from the prior year. Free cash flow is robust at $639.4 million TTM, and the balance sheet is healthy with a debt-to-equity of 0.234. The implied upside to analyst targets is 24.5%, but the stock's negative relative strength (-28.3% over 1 year) suggests it may take time to realize.
The biggest risks that could invalidate the thesis include a continued slowdown in commercial construction, margin compression from competition, and a failure to meet the optimistic forward EPS estimate of $24.62. The rating would upgrade to Buy if revenue growth accelerates above 5% or if the forward PE remains below 15x with improving sentiment. Conversely, a downgrade to Sell would occur if revenue declines or margins contract significantly. Relative to its history, the stock is undervalued on a forward basis, but fairly valued on a trailing basis, suggesting a balanced risk/reward profile.
Sign up to view all
AYI 12-Month Price Forecast
Acuity presents a balanced risk/reward profile. The company's strong margin expansion and cash flow generation are offset by weak revenue growth and negative relative performance. The forward valuation is attractive, but the market is pricing in significant earnings growth that may be challenging to achieve without an acceleration in revenue. The recent analyst downgrade and high short ratio suggest near-term pressure. I would upgrade to bullish if revenue growth accelerates above 5% or if the stock breaks above $350 resistance with strong volume. Conversely, a downgrade to bearish would occur if revenue declines or if margins contract, leading to a retest of the 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Acuity Brands's 12-month outlook, with a consensus price target around $379.33 and implied upside of +24.4% versus the current price.
Average Target
$379.33
0 analysts
Implied Upside
+24.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$345 - $440
Analyst target range
Acuity is covered by 7 analysts, with a consensus recommendation of "Buy" and an average target price of $384.43. This implies an upside of approximately 24.5% from the current price of $308.76. The recommendation mean is 2.25, which falls between "Buy" and "Hold," indicating a moderately bullish sentiment. The estimated EPS average for the next fiscal year is $24.62, with a range of $24.05 to $25.14, and estimated revenue average of $5.093 billion. The consensus leans bullish, but the recent downgrade by William Blair from Outperform to Market Perform on September 28, 2026, suggests some caution. The average target price is well above the current price, reflecting confidence in the company's earnings growth and margin expansion.
The target price range is wide, from a low of $345.00 to a high of $440.00, representing a spread of 27.5% around the average. The high target of $440 implies a 42.5% upside and assumes successful execution of the AIS growth strategy, further margin expansion, and multiple expansion. The low target of $345 implies an 11.7% upside and likely prices in slower growth, margin compression, or a challenging macroeconomic environment. The wide spread indicates high uncertainty among analysts, which is consistent with the stock's recent volatility and the mixed institutional ratings. Recent actions show Baird maintaining Neutral, Morgan Stanley maintaining Overweight, and Wells Fargo maintaining Overweight, but the William Blair downgrade is a negative signal. The lack of recent upgrades and the presence of downgrades suggest that analyst sentiment may be shifting, and the stock could remain under pressure until there is clearer evidence of accelerating growth.
Bulls vs Bears: AYI Investment Factors
The bullish case for Acuity rests on its impressive margin expansion, strong cash flow, and attractive forward valuation, which suggest the stock is undervalued relative to its earnings growth potential. However, the bearish case highlights weak revenue growth, negative relative performance, and a recent analyst downgrade, indicating that the company faces challenges in accelerating top-line growth. The most critical tension is whether Acuity can sustain its margin improvements and translate them into consistent earnings growth to justify the optimistic forward EPS estimates. Currently, the bearish evidence appears slightly stronger due to the stock's poor relative strength and downgrade, but the valuation and cash flow provide a solid foundation for a potential turnaround if growth reaccelerates.
Bullish
- Strong Margin Expansion: Gross margin expanded to 50.62% in Q3 2026 from 48.38% a year ago, while operating margin jumped to 16.14% from 11.86%. This 428 basis point improvement in operating margin demonstrates significant operating leverage and pricing power.
- Attractive Forward Valuation: Forward PE of 13.23x is well below the trailing PE of 18.97x and the broader market average, implying a 30% earnings growth expectation. The PEG ratio of 0.53 suggests the stock is undervalued relative to its growth rate.
- Robust Free Cash Flow: TTM free cash flow was $639.4 million, with Q3 2026 FCF of $273.6 million, up 42% year-over-year. This strong cash generation supports buybacks ($126.9 million in Q3) and dividends.
- Analyst Consensus Upside: The average analyst target price of $384.43 implies 24.5% upside from the current price of $308.76. With 7 analysts covering, the consensus recommendation is 'Buy' (mean 2.25).
Bearish
- Weak Revenue Growth: Q3 2026 revenue grew only 1.65% year-over-year to $1.198 billion, and revenue has been range-bound between $1.0-$1.2 billion for two years. This suggests limited organic expansion and dependence on margin improvement rather than top-line growth.
- Negative Relative Performance: The stock has declined 13.3% over the past year while the S&P 500 gained 15.0%, resulting in a relative strength of -28.3%. Over the past three months, it underperformed by 17.3%, indicating persistent weakness.
- Recent Analyst Downgrade: William Blair downgraded the stock from Outperform to Market Perform on September 28, 2026, citing a selective market environment. This negative signal contrasts with the consensus 'Buy' rating and may pressure the stock.
- High Volatility and Drawdown: The stock experienced a max drawdown of -31.56% over the past year, and its 52-week range is wide ($257.04 to $380.17). This volatility increases risk for investors, especially with a short ratio of 5.34 indicating bearish sentiment.
AYI Technical Analysis
Acuity's stock is in a recovery phase within a broader range-bound consolidation. Over the past year, the stock has declined 13.3%, while the S&P 500 gained 15.0%, resulting in a significant relative strength of -28.3%. The current price of $308.76 sits at approximately 42% of its 52-week range of $257.04 to $380.17, indicating that it is closer to the lower end of its annual range. This positioning suggests that the stock has been out of favor and may be forming a base, but it remains well below its highs, reflecting lingering bearish sentiment. The 6-month price change of +16.3% shows a notable rebound from the lows, but the 1-year decline underscores the longer-term downtrend that has yet to be fully reversed.
Short-term momentum has been negative, with a 1-month decline of -6.6% and a 3-month decline of -14.0%, both underperforming the S&P 500's respective gains of 0.59% and 3.34%. This recent weakness contrasts with the positive 6-month performance, suggesting a deceleration in momentum after a strong spring rally. The relative strength over the past month is -7.2%, indicating that the stock is lagging the market by a wide margin. The divergence between the 6-month gain and the 1-month loss could signal a temporary pullback within a recovery, but the failure to hold above $350 in July and August raises concerns about a potential trend reversal. Volume data is not available for detailed analysis, but the recent price action suggests distribution.
Key technical levels are defined by the 52-week low of $257.04 and the 52-week high of $380.17. A breakdown below the recent support near $296 (the September low) could open the door to a retest of the 52-week low, while a breakout above the $340-$350 resistance zone would signal a potential trend change. The stock's beta is not provided, but the max drawdown of -31.56% over the past year indicates significant volatility, with the stock experiencing sharp declines. The current price is 19.6% above the 52-week low and 18.8% below the 52-week high, placing it in the middle of its range. For risk management, the wide trading range and negative relative strength warrant caution, and position sizing should account for the potential for further downside if support levels fail.
Beta
1.30
1.30x market volatility
Max Drawdown
-31.6%
Largest decline past year
52-Week Range
$257-$380
Price range past year
Annual Return
-13.6%
Cumulative gain past year
| Period | AYI Return | S&P 500 |
|---|---|---|
| 1m | -8.7% | +0.6% |
| 3m | -10.1% | +3.6% |
| 6m | +8.0% | +14.6% |
| 1y | -13.6% | +15.8% |
| ytd | -18.3% | +13.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AYI Fundamental Analysis
Acuity's revenue trajectory has been modestly growing, with the most recent quarter (Q3 2026, ended May 31, 2026) reporting revenue of $1.198 billion, up 1.65% year-over-year from $1.179 billion in Q3 2025. Sequentially, revenue increased from $1.056 billion in Q2 2026 and $1.144 billion in Q1 2026, showing a seasonal uptick. However, the growth rate is relatively low, and the company's revenue has been fluctuating around the $1.0-$1.2 billion quarterly range for the past two years. The ABL segment remains the dominant contributor with $817.4 million in sales, while the AIS segment contributed $248.1 million, representing about 23% of total segment revenue. The modest growth suggests a mature market with limited organic expansion, and future growth will likely depend on AIS penetration and pricing power.
Profitability has been strong, with Q3 2026 net income of $141.0 million and a net margin of 11.77%, up from 8.35% in the prior-year quarter. Gross margin expanded to 50.62% in Q3 2026 from 48.38% in Q3 2025, reflecting favorable product mix and cost management. Operating margin also improved to 16.14% from 11.86% a year ago, driven by higher gross margins and operating leverage. The company's EBITDA margin was 19.51% in Q3 2026, compared to 14.81% in Q3 2025, indicating significant margin expansion. This profitability improvement is a key positive, as it demonstrates the company's ability to enhance earnings even with modest revenue growth.
The balance sheet remains healthy, with a debt-to-equity ratio of 0.234, a current ratio of 1.69, and a quick ratio of 1.47, indicating ample liquidity. Free cash flow for the trailing twelve months was $639.4 million, and in Q3 2026 alone, free cash flow was $273.6 million, up from $192.3 million in the prior-year quarter. The company generated $290.3 million in operating cash flow in Q3 2026, with capital expenditures of only $16.7 million, resulting in a high FCF conversion. ROE was 17.86%, and ROA was 9.57%, reflecting efficient capital use. With $411.9 million in cash and no significant debt repayments in the quarter, Acuity has the financial flexibility to fund growth initiatives and return capital to shareholders through buybacks ($126.9 million in Q3 2026) and dividends.
Quarterly Revenue
$1.2B
2026-05
Revenue YoY Growth
+1.7%
YoY Comparison
Gross Margin
50.6%
Latest Quarter
Free Cash Flow
$639400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AYI Overvalued?
Since Acuity is profitable with positive net income of $141.0 million in the most recent quarter, the PE ratio is the appropriate primary valuation metric. The trailing PE is 18.97x, while the forward PE is 13.23x, based on estimated EPS of $24.62 for the next fiscal year. The significant gap between trailing and forward PE implies that the market expects strong earnings growth, with forward EPS implying a 30% increase over trailing EPS of $18.97 (calculated as price divided by trailing PE). This suggests that analysts anticipate continued margin expansion and earnings acceleration, which is a bullish signal if the company can deliver.
Compared to the industry average, Acuity's valuation appears mixed. The industry average PE for Electrical Equipment & Parts is not provided, but the stock's PS ratio of 2.17x and EV/EBITDA of 14.21x can be contextualized. The PS ratio is relatively low, but the EV/EBITDA is moderate. The PEG ratio of 0.53 is notably low, suggesting that the stock is undervalued relative to its expected growth rate. However, without direct peer comparisons, it is difficult to quantify the premium or discount. The forward PE of 13.23x is below the broader market average, which may indicate that the stock is priced for slower growth or that it is undervalued. The dividend yield is minimal at 0.24%, and the payout ratio is only 4.48%, indicating that the company retains most earnings for reinvestment.
Historically, Acuity's PE ratio has ranged from a low of 11.38x in Q3 2023 to a high of 29.71x in Q2 2025. The current trailing PE of 18.97x is near the middle of this historical range, but the forward PE of 13.23x is near the lower end, suggesting that the market is pricing in optimistic earnings growth. The PS ratio of 2.17x is significantly lower than the historical average of around 7-8x, but this is due to the recent decline in the stock price and the increase in revenue. The price-to-book ratio of 3.39x is also below the historical highs of over 4x, indicating that the stock is not expensive relative to its book value. Overall, the valuation appears reasonable, with the forward PE suggesting upside if earnings meet expectations.
PE
19.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.3x
Enterprise Value Multiple
Investment Risk Disclosure
Acuity's financial risks are relatively contained but not negligible. The debt-to-equity ratio of 0.234 is low, and the current ratio of 1.69 indicates ample liquidity, reducing immediate solvency concerns. However, the company's revenue growth is anemic at 1.65% year-over-year, and its net margin, while improved to 11.77% in Q3 2026, remains vulnerable to cost pressures or a slowdown in commercial construction. Additionally, the payout ratio is only 4.48%, meaning the dividend offers minimal income support, and the company relies on buybacks ($126.9 million in Q3) to return capital, which could be curtailed if cash flow declines.
Market and competitive risks are significant. The stock trades at a forward PE of 13.23x, which is below the market average but may reflect skepticism about growth. If the company fails to meet the 30% earnings growth implied by this multiple, the stock could de-rate further. The recent downgrade by William Blair highlights concerns about a selective market environment where execution is paramount. With a beta not provided but a max drawdown of -31.56% over the past year, the stock is volatile and sensitive to market rotations, especially away from industrial cyclicals. Commercial construction exposure adds cyclicality, and competition in the lighting and intelligent building space could pressure pricing and margins.
The worst-case scenario for Acuity would involve a combination of slowing commercial construction activity, margin compression due to competitive pressures, and a failure to achieve the projected earnings growth. In this scenario, the stock could retest its 52-week low of $257.04, representing a 16.7% decline from the current price of $308.76. If the bear case target of $345 (analyst low) is breached, the next support is at the 52-week low, implying a potential loss of approximately 16.7% from current levels. A more severe downturn, such as a recession, could push the stock below $257, but that would require a significant deterioration in fundamentals. Investors should be prepared for a drawdown of at least 15-20% in adverse conditions.
FAQ
The key risks for AYI include: 1) Financial risk: Revenue growth is stagnant at 1.65%, and any margin compression could hurt earnings. 2) Market risk: The stock has a high max drawdown of -31.56% and negative relative strength, indicating volatility and potential for further declines. 3) Competitive risk: The lighting and intelligent building space is competitive, and Acuity may face pricing pressure. 4) Macro risk: Exposure to commercial construction makes it sensitive to economic cycles. The most severe risk is a recession that reduces demand, potentially driving the stock to its 52-week low of $257.04, a 16.7% drop from current levels.
Our 12-month forecast for AYI includes three scenarios: Bull case (25% probability) with a target range of $384-$440, driven by revenue acceleration and margin expansion; Base case (55% probability) with a target range of $345-$384, assuming steady execution and meeting analyst estimates; Bear case (20% probability) with a target range of $257-$345, triggered by a commercial construction slowdown and earnings misses. The most likely scenario is the base case, where the stock trades in line with the analyst average target of $384.43, implying 24.5% upside. The key assumption is that revenue growth remains modest but margins hold, and the company continues to generate strong free cash flow.
AYI appears undervalued on a forward basis. The forward PE of 13.23x is significantly below the trailing PE of 18.97x and the broader market average, suggesting the market expects strong earnings growth. The PEG ratio of 0.53 is well below 1, indicating undervaluation relative to growth. However, the PS ratio of 2.17x is low compared to historical averages of 7-8x, but this is due to the stock's decline. The EV/EBITDA of 14.21x is moderate. Overall, the valuation implies the market is pricing in optimistic earnings growth, and if the company delivers, the stock could re-rate higher. But if growth disappoints, the stock could be fairly valued or even overvalued.
From a risk/reward perspective, AYI offers a balanced proposition. The stock trades at a forward PE of 13.23x, which is attractive given the estimated EPS growth of 30%, and the average analyst target of $384.43 implies 24.5% upside. However, the company's revenue growth is only 1.65% year-over-year, and the stock has underperformed the S&P 500 by 28.3% over the past year. The biggest downside risk is a retest of the 52-week low at $257.04, representing a 16.7% decline. For value investors with a long-term horizon, AYI could be a good buy on weakness, but near-term catalysts are lacking. It is not a screaming buy, but rather a hold with a bullish bias for those willing to wait for growth to materialize.
AYI is more suitable for long-term investment. The company has a stable business model, strong cash flow, and a healthy balance sheet, but its growth is slow and the stock is volatile (max drawdown of -31.56%). Short-term trading would be risky due to the lack of near-term catalysts and negative momentum. The dividend yield is minimal at 0.24%, so income is not a reason to hold. For long-term investors, the potential for margin expansion and AIS growth could drive earnings and multiple expansion over 2-3 years. A suggested minimum holding period is 2-3 years to allow for the intelligent building strategy to mature and for commercial construction cycles to play out.